Max Hodak's Science Corp raises $400 million at a $3.5 billion valuation

The brain-interface company behind the PRIMA retinal implant, which is approved in Europe, closed a Series D with investors including Khosla Ventures.
Why it matters
Science Corp was founded by Max Hodak, a Neuralink co-founder, and is one of the few brain-interface companies with a product already approved for patients. PRIMA helps people with advanced macular degeneration regain some sight, and it is already available in Germany. The new round values the company well above most of its rivals in the field.
Key facts
- $400 million Series D
- Valuation of $3.5 billion
- PRIMA retinal implant approved in Europe
- Founded by Neuralink co-founder Max Hodak